| 357287-98-0 | (5-Methylpyridin-2-yl)methanamine dihydrochloride |
| 357288-02-9 | (3-Methylpyridin-2-yl)methanamine hydrochloride |
| 357289-65-7 | 2-Furancarboxylicacid,4-cyano-,methylester(9CI) |
| 357290-69-8 | 2-Butyn-1-amine,N-methyl-4-phenoxy-(9CI) |
| 357291-91-9 | 2-Thiophenecarboxamide,N-[3-(dimethylamino)phenyl]-(9CI) |
| 357294-38-3 | Acetonitrile, oxo[(phenylmethylene)hydrazino]- (9CI) |
| 357294-45-2 | Acetonitrile, [[(4-ethoxyphenyl)methylene]hydrazino]oxo- (9CI) |
| 357294-71-4 | Acetic acid, [1-(4-ethoxyphenyl)ethylidene]hydrazide (9CI) |
| 357295-15-9 | Acetic acid, (4-cyano-2,2-dimethylbutylidene)hydrazide (9CI) |
| 357295-86-4 | Acetonitrile, [[1-(2,5-dihydroxyphenyl)ethylidene]hydrazino]oxo- (9CI) |
| 357297-08-6 | Acetonitrile, [(1-methyl-4-piperidinylidene)hydrazino]oxo- (9CI) |
| 357302-54-6 | 1-[3-(1,3-DIHYDRO-2H-ISOINDOL-2-YL)PHENYL]-1-ETHANONE |
| 357317-99-8 | 2-METHYL-INDOLIZINE-1,3-DICARBALDEHYDE |
| 357326-67-1 | N-(2,3-DIMETHYLPHENYL)-3,5-DIMETHYL-4-ISOXAZOLECARBOXAMIDE |
| 357326-79-5 | ETHYL 5-ISOPROPYL-3-METHYLISOXAZOLE-4-CARBOXYLATE |
| 357330-15-5 | 1,3-Dioxolane-4-carboxaldehyde, 4-ethyl-2,2-dimethyl- (9CI) |
| 357332-70-8 | 3-Thiophenecarboxylicacid,2-amino-4-ethyl-,ethylester(9CI) |
| 357334-83-9 | 1-Pyrrolidineacetamide, α-ethyl-4-(1-methylethyl)-2-oxo-, (αS,4S)- |
| 357335-87-6 | Brivaracetam (Racemate) |
| 357336-17-5 | 1-Pyrrolidineacetamide, 4-(2,2-difluoroethenyl)-α-ethyl-2-oxo- |
| 357336-19-7 | (4S)-BrivaracetaM |
| 357336-20-0 | Brivaracetam |
| 357336-74-4 | Seletracetam |
| 357336-99-3 | Brivaracetam (alfaR, 4S)-Isomer |
| 357337-00-9 | Brivaracetam (alfaR, 4R)-Isomer |
| 357338-13-7 | (S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide |
| 357338-16-0 | 4-(3-CHLOROPHENYL)PYRROLIDIN-2-ONE |
| 357338-46-6 | Brivaracetam Impurity 7 HCl |
| 357339-96-9 | ZNAF-2 DA |
| 357383-27-8 | 2-amino-(1,6-dimethylfuro(3,2-e)imidazo(4,5-b))pyridine |
| 357385-69-4 | Carbamic acid, [(1R)-1-(2S)-oxiranylethyl]-, 1,1-dimethylethyl ester (9CI) |
| 357385-70-7 | Carbamic acid, [(1R)-1-(2R)-oxiranylethyl]-, 1,1-dimethylethyl ester (9CI) |
| 357391-80-1 | 4-[[(5-chloro-2-methyl-phenyl)-phenylsulfonyl-amino]methyl]benzoic acid |
| 357397-42-3 | 1H-Indole-5,6-diol, 2,3-dihydro-1,3,3-trimethyl-2-methylene- (9CI) |
| 357397-44-5 | 1H-Indole-4,5-diol, 2,3-dihydro-1,3,3-trimethyl-2-methylene- (9CI) |
| 357399-43-0 | BUPROPION MORPHOLINOL |
| 357400-13-6 | NNC 55-0396 dihydrochloride |
| 357401-12-8 | Hydrazinecarboxylic acid, [2-hydroxy-1-(hydroxymethyl)ethylidene]-, 1,1- |
| 357401-15-1 | (1,3-bis(benzyloxy)propan-2-yl)hydrazine hemioxalate |
| 357401-40-2 | 1-Propanone, 1-(3,5-di-β-D-glucopyranosyl-2,4,6-trihydroxyphenyl)-3-(4-hydroxyphenyl)- |
| 357402-37-0 | Acetonitrile, oxo[(2-thienylmethylene)hydrazino]- (9CI) |
| 357404-25-2 | Acetonitrile, oxo[(3-pyridinylmethylene)hydrazino]- (9CI) |
| 357404-55-8 | Benzonitrile, 5-fluoro-2-hydroxy-4-methyl- (9CI) |
| 357405-29-9 | 5-Isoxazolecarboxamide,N-methoxy-N-methyl-(9CI) |
| 357405-31-3 | 1-Propanone,3-chloro-1-(5-isoxazolyl)-(9CI) |
| 357405-33-5 | 5-Isoxazolemethanol,-alpha--(2-chloroethyl)-(9CI) |
| 357405-40-4 | 5-Isoxazolemethanol,-alpha--(2-chloroethyl)-,(-alpha-S)-(9CI) |
| 357405-56-2 | N-methoxy-N-methylthiophene-3-carboxamide |
| 357405-75-5 | 4-bromo-2,5-difluorobenzaldehyde |
| 357405-87-9 | 1-Propanone,3-chloro-1-(3-isoxazolyl)-(9CI) |
| 357405-89-1 | 3-Isoxazolemethanol,-alpha--(2-chloroethyl)-,(-alpha-S)-(9CI) |
| 357405-94-8 | 3-Isoxazolemethanol,-alpha--(2-chloroethyl)-,(-alpha-R)-(9CI) |
| 357405-99-3 | Acetonitrile, oxo[(4-pyridinylmethylene)hydrazino]- (9CI) |
| 357407-86-4 | (R)-(+)-N-METHYL-1-PHENYLETHYLAMINE-D13 |
| 357407-89-7 | 1H-Indene-1,2(3H)-dione,6-ethoxy-,2-oxime(9CI) |
| 357407-90-0 | 1H-Inden-1-ol,2-amino-6-ethoxy-2,3-dihydro-,(1R,2R)-rel-(9CI) |
| 357407-91-1 | 1H-Inden-1-ol,2-amino-6-ethoxy-2,3-dihydro-,(1S,2S)-(9CI) |
| 357407-97-7 | 2-AMINO-6-METHOXY-INDAN-1-OL HYDROCHLORIDE |
| 357407-99-9 | 1H-Inden-2-amine,2,3-dihydro-5-methoxy-,(2S)-(9CI) |
| 357410-18-5 | N-(1-naphthyl)-2-[2-(1-naphthylmethylene)hydrazino]-2-oxoacetamide |
| 357416-82-1 | (S)-Methyl 4-(Boc-amino)-2-hydroxybutanoate |
| 357418-50-9 | 3-Cyclohexene-1-carboxylicacid,1-methyl-,methylester,(1R)-(9CI) |
| 357418-53-2 | 3-Cyclohexene-1-carboxylicacid,1-methyl-,methylester,(1S)-(9CI) |
| 357420-38-3 | 2-[(2,5-DIMETHYL-FURAN-3-CARBONYL)-AMINO]-BENZOIC ACID |
| 357420-44-1 | 5-Oxazolidinemethanol,2,3-dimethyl-2-(1-methylethyl)-(9CI) |
| 357420-95-2 | Benzoic acid, 4-methoxy-, [[5-(dimethylamino)-2-furanyl]methylene]hydrazide (9CI) |
| 357423-77-9 | Phenol, 4-methoxy-2-[(methylimino)methyl]- (9CI) |
| 357424-07-8 | Varenicline Impurity 13 |
| 357424-12-5 | 5,9-Methanoimidazo[4,5-h][3]benzazepine,1,5,6,7,8,9-hexahydro-(9CI) |
| 357424-21-6 | Hydroxy Varenicline |
| 357425-02-6 | CP-601927 |
| 357425-68-4 | CP-601932 |
| 357426-10-9 | Hydroxy Varenicline N-Trifluoroacetate |
| 357426-12-1 | methyl 3-(aminomethyl)-2,3-dihydro-1H-indene-1-carboxylate |
| 357426-13-2 | 1,3,4,5-Tetrahydro-1,5-methano-2H-3-benzazepin-2-one |
| 357426-83-6 | 2-Oxazolidinone,4-(1-methylethyl)-3-(1,2-propadienyl)-,(4R)-(9CI) |
| 357427-66-8 | 1,2-Benzenedimethanol,-alpha-,-alpha--diethyl-,(-alpha-S,-alpha-S)-(9CI) |
| 357427-68-0 | 1,2-Benzenedimethanol,-alpha-,-alpha--diethyl-,(-alpha-R,-alpha-R)-(9CI) |
| 357427-84-0 | 1,2-Benzenedimethanol,-alpha--ethyl--alpha--methyl-,(-alpha-S,-alpha-S)-(9CI) |
| 357428-36-5 | 1H,5H-Pyrrolo[2,1-c][1,4]oxazepin-5-one,hexahydro-3-methoxy-,(3S,9aS)-(9CI) |
| 357428-48-9 | 1H,5H-Pyrrolo[2,1-c][1,4]oxazepin-5-one,hexahydro-3-methoxy-,(3R,9aS)-(9CI) |
| 357437-74-2 | 3,6-DIBROMO-9-(P-TOLYL)-9H-CARBAZOLE |
| 357443-58-4 | tert-butyl 4-amino-4-phenylbutylcarbamate |
| 357608-23-2 | 4,7-dihydro-1-Methyl-4,7-Ethano-2H-isoindole |
| 357608-93-6 | 4-(DIETHYLAMINO)-3-NITROPYRIDINE |
| 357608-96-9 | 1-[2-(DIETHYLAMINO)-5-NITRO-4-PYRIDINYL]-ETHANONE |
| 357610-31-2 | N-BOC-BETA-ALANINE-BETA-METHYL-N-CARBOXYANHYDRIDE
|
| 357610-32-3 | N-BOC-BETA-ALANINE-ALPHA-METHYL-N-CARBOXYANHYDRIDE
|
| 357610-78-7 | 1H-Phenalene-5,6-diol, 2,3,7,9a-tetrahydro- (9CI) |
| 357611-22-4 | 2-tert-butyl-4-fluorophenol |
| 357611-51-9 | 3,5-DIMETHYL-4-PROPOXYPHENYLBORONIC ACID |
| 357613-02-6 | Benzenemethanethiol, 2-fluoro-3-methyl- (9CI) |
| 357613-07-1 | Benzenemethanethiol, 2-fluoro-5-methyl- (9CI) |
| 357613-77-5 | galiximab |
| 357613-86-6 | Lumiliximab |
| 357616-16-1 | N-(3-HYDROXYPROPYL)-1H-INDOLE-2-CARBOXAMIDE |
| 357618-22-5 | 2-(4-pyridinyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one |
| 357618-26-9 | 5-(3-hydroxyphenyl)-8-thia-4,6-diazatricyclo[7.4.0.0,2,7]trideca-1(9),2(7),5-trien-3-one |
| 357625-18-4 | 1-Naphthalenol,2-fluoro-1,2-dihydro-,(1R,2R)-(9CI) |
| 357627-48-6 | 1-Indolizinemethanol(9CI) |